Caplin Point Laboratories shares jumped on Thursday after the company's state of art injectable plant near Gummidipoondi, Tamil Nadu to cater regulated markets USA, EU, Brazil, South Africa etc., has commenced its commercial production on Mar. 27, 2014.

This will now enable export of these products to semi regulated and non regulated markets.

Shares of the company are trading at Rs 175.50, up Rs 8.35, or 5% at the Bombay Stock Exchange (BSE) on Thursday at 12:23 p.m.

The scrip has touched an intra-day high of Rs 175.50 and low of Rs 163.15. The total volume of shares traded at the BSE is 30,791.

In the earlier session, the shares declined 2.45%, or Rs 4.2, at Rs 167.15.

Currently, the stock is trading down 2.82% from its 52-week high of Rs 180.60 and above 306.72% over the 52-week low of Rs 43.15.